S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)

Globus Medical (GMED) Earnings Date, Estimates & Call Transcripts

$54.47
+0.48 (+0.89%)
(As of 03/1/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 2Estimated
Actual EPS
(Feb. 20)
$0.60 Beat By $0.01
Consensus EPS
(Feb. 20)
$0.59
Skip Charts & View Estimated and Actual Earnings Data

GMED Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GMED Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Globus Medical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$0.49$0.56$0.53 
Q2 20242$0.63$0.66$0.65 
Q3 20242$0.62$0.71$0.67 
Q4 20242$0.68$0.85$0.77 
FY 20248$2.42$2.78$2.60 
Q1 20251$0.66$0.66$0.66 
Q2 20251$0.70$0.70$0.70 
Q3 20251$0.68$0.68$0.68 

GMED Earnings Date and Information

Globus Medical last posted its quarterly earnings results on February 20th, 2024. The medical device company reported $0.60 EPS for the quarter, beating analysts' consensus estimates of $0.59 by $0.01. The firm had revenue of $616.53 million for the quarter, compared to analysts' expectations of $608.21 million. Its revenue for the quarter was up 124.6% compared to the same quarter last year. Globus Medical has generated $1.17 earnings per share over the last year ($1.17 diluted earnings per share) and currently has a price-to-earnings ratio of 46.5. Earnings for Globus Medical are expected to grow by 22.85% in the coming year, from $2.67 to $3.28 per share. Globus Medical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.

Globus Medical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Estimated)
------- 
2/20/2024Q4 2023$0.59$0.60+$0.01$1.09$608.21 million$616.53 million    
11/7/2023Q3 2023$0.54$0.57+$0.03$1.13$306.78 million$383.60 million    
8/3/2023Q2 2023$0.60$0.63+$0.03$0.69$279.54 million$291.62 million    
5/4/2023Q1 2023$0.51$0.53+$0.02$0.58$254.05 million$276.90 million    
2/21/2023Q4 2022$0.55$0.59+$0.04$0.69$276.40 million$274.50 million    
11/8/2022Q3 2022$0.52$0.50($0.02)$0.53$252.94 million$254.15 million
8/4/2022Q2 2022$0.54$0.56+$0.02$0.59$258.48 million$263.65 million
5/10/2022Q1 2022$0.46$0.42($0.04)$0.47$232.88 million$230.55 million    
2/17/2022Q4 2021$0.48$0.49+$0.01$0.84$243.93 million$250.02 million    
11/4/2021Q3 2021$0.45$0.50+$0.05$0.55$228.28 million$229.72 million    
8/4/2021Q2 2021$0.44$0.56+$0.12$0.72$225.50 million$251.02 million    
5/4/2021Q1 2021$0.37$0.49+$0.12$0.54$196.89 million$227.34 million  












Globus Medical Earnings - Frequently Asked Questions

When is Globus Medical's earnings date?

Globus Medical has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on GMED's earnings history.

Did Globus Medical beat their earnings estimates last quarter?

In the previous quarter, Globus Medical (NYSE:GMED) reported $0.60 earnings per share (EPS) to beat the analysts' consensus estimate of $0.59 by $0.01. Learn more on analysts' earnings estimate vs. GMED's actual earnings.

How can I listen to Globus Medical's earnings conference call?

The conference call for Globus Medical's latest earnings report can be listened to online. Listen to Conference Call

How can I read Globus Medical's conference call transcript?

The conference call transcript for Globus Medical's latest earnings report can be read online. Read Transcript

How much revenue does Globus Medical generate each year?

Globus Medical (NYSE:GMED) has a recorded annual revenue of $1.02 billion.

How much profit does Globus Medical generate each year?

Globus Medical (NYSE:GMED) has a recorded net income of $122.87 million. GMED has generated $1.17 earnings per share over the last four quarters.

What is Globus Medical's price-to-earnings ratio?

Globus Medical (NYSE:GMED) has a trailing price-to-earnings ratio of 46.54 and a forward price-to-earnings ratio of 20.40. The price/earnings-to-growth ratio is 1.62.

What is Globus Medical's EPS forecast for next year?

Globus Medical's earnings are expected to grow from $2.67 per share to $3.28 per share in the next year, which is a 22.85% increase.


More Earnings Resources from MarketBeat

This page (NYSE:GMED) was last updated on 3/1/2024 by MarketBeat.com Staff